BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35799026)

  • 1. On logistic regression with right censored data, with or without competing risks, and its use for estimating treatment effects.
    Blanche PF; Holt A; Scheike T
    Lifetime Data Anal; 2023 Apr; 29(2):441-482. PubMed ID: 35799026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
    Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
    J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented and doubly robust G-estimation of causal effects under a Structural nested failure time model.
    Mertens K; Vansteelandt S
    Biometrics; 2018 Jun; 74(2):472-480. PubMed ID: 28742252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring.
    Latimer NR; Abrams KR; Siebert U
    BMC Med Res Methodol; 2019 Mar; 19(1):69. PubMed ID: 30935369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverse probability weighted estimators of vaccine effects accommodating partial interference and censoring.
    Chakladar S; Rosin S; Hudgens MG; Halloran ME; Clemens JD; Ali M; Emch ME
    Biometrics; 2022 Jun; 78(2):777-788. PubMed ID: 33768557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inverse probability weighted regression method that accounts for right-censoring for causal inference with multiple treatments and a binary outcome.
    Yu Y; Zhang M; Mukherjee B
    Stat Med; 2023 Sep; 42(20):3699-3715. PubMed ID: 37392070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating causal effects for multivalued treatments: a comparison of approaches.
    Linden A; Uysal SD; Ryan A; Adams JL
    Stat Med; 2016 Feb; 35(4):534-52. PubMed ID: 26482211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized mean residual life models for survival data with missing censoring indicators.
    Li W; Ma H; Faraggi D; Dinse GE
    Stat Med; 2023 Feb; 42(3):264-280. PubMed ID: 36437483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance for prognostic models with competing risks.
    Wolbers M; Blanche P; Koller MT; Witteman JC; Gerds TA
    Biostatistics; 2014 Jul; 15(3):526-39. PubMed ID: 24493091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
    Matsuyama Y; Yamaguchi T
    Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression modeling of restricted mean survival time for left-truncated right-censored data.
    Rong R; Ning J; Zhu H
    Stat Med; 2022 Jul; 41(16):3003-3021. PubMed ID: 35708238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-observations for competing risks with covariate dependent censoring.
    Binder N; Gerds TA; Andersen PK
    Lifetime Data Anal; 2014 Apr; 20(2):303-15. PubMed ID: 23430270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiparametric estimation of structural nested mean models with irregularly spaced longitudinal observations.
    Yang S
    Biometrics; 2022 Sep; 78(3):937-949. PubMed ID: 33870495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the quantile medical cost under time-dependent covariates and right censored time-to-event variable based on a state process.
    Liu X; Deng D; Wang D
    Stat Methods Med Res; 2020 Aug; 29(8):2041-2062. PubMed ID: 31640484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjustment for treatment changes in epilepsy trials: A comparison of causal methods for time-to-event outcomes.
    Dodd S; Williamson P; White IR
    Stat Methods Med Res; 2019 Mar; 28(3):717-733. PubMed ID: 29117780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
    Yoshida M; Matsuyama Y; Ohashi Y;
    Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression with a right-censored predictor using inverse probability weighting methods.
    Matsouaka RA; Atem FD
    Stat Med; 2020 Nov; 39(27):4001-4015. PubMed ID: 32779274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doubly-robust methods for differences in restricted mean lifetimes using pseudo-observations.
    Choi S; Choi T; Lee HY; Han SW; Bandyopadhyay D
    Pharm Stat; 2022 Nov; 21(6):1185-1198. PubMed ID: 35524651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.